论文部分内容阅读
Heat shock protein 90 (Hsp90) takes part in the developments of several cancers.Novobiocin,a typicallyC-terminal inhibitor for Hsp90,is probably used as an important anticancer drug in the future.In this work,weexplored the valuable information and designed new novobiocin derivatives based on three-dimensionalquantitative structure-activity relationship (3D QSAR).